Basel, Basel, Switzerland
I am enthusiastic about accelerating biomedical progress by supporting life science companies. The next breakthrough in terms of modalities may be tissue engineering. I believe in moonshots that are based on solid science.
Preclinical biotech company working on the integrity of the blood brain barrier
Preclinical biotech company with an enzyme platform that targets crosslinks like AGE (advanced glycation end products)
Kizoo is an early-stage investor in longevity biotech companies